Huda Fatima

Huda Fatima

Auto-generated profile, based on publicly available information

Huda Fatima

General Medicine Practice , Batterjee Medical College , Jeddah , Saudi Arabia , bmc.edu.sa

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in International Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
FAFatima Shafiya Ali
Fatima Shafiya Ali
HFHuda Fatima
Huda Fatima
ZAZainab Jasim Alqurain
Zainab Jasim Alqurain
ATAroob Abdullah Takruni
Aroob Abdullah Takruni
SHSana Hashim
Sana Hashim
MPMable Pereira
Mable Pereira
Background: Depression and anxiety occur in about 10% of pregnancies. Selective serotonin reuptake inhibitors (SSRIs) are often prescribed, but their potential effects on fetal neurodevelopment remain uncertain. Because serotonin influences brain maturation, prenatal SSRI exposure may affect later cognition, language, or motor function. Methods: This systematic review and meta‐analysis evaluated whether prenatal SSRI exposure is associated with differences in child cognitive, language, or psychomotor development. PubMed and Scopus were searched through June 2025 for cohort, case‐control, or randomized studies reporting standardized neurodevelopmental outcomes in children (0–18 years) with documented in utero SSRI exposure compared with unexposed controls. Two reviewers independently screened studies, extracted data, and assessed bias (Newcastle–Ottawa Scale; RoB‐2). Random‐effects meta‐analyses estimated standardized mean differences (SMDs) with 95% confidence intervals (CIs). Results: Of 250 records identified, 17 studies met inclusion criteria, and 9 contributed to meta‐analysis. For general cognition, pooled SMD = −0.20 (95% CI −0.50 to 0.10) showed no significant difference between groups. Sensitivity analyses restricted to SSRI‐only cohorts and Bayley‐specific instruments yielded similar findings. Secondary outcomes also showed no differences: receptive language (SMD = 0.04; 95% CI −0.16 to 0.23), expressive language (SMD = −0.17; 95% CI −0.40 to 0.06), and psychomotor development (SMD = −0.18; 95% CI −0.67 to 0.31). Conclusions: Current evidence does not support a clinically meaningful impact of prenatal SSRI exposure on early cognitive, language, or psychomotor development. Observed effects were small, imprecise, and diminished when analyses were limited to SSRI‐only cohorts and harmonized outcome measures.